Journey Medical (DERM) Asset Utilization Ratio (2021 - 2026)

Journey Medical has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.69 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 1.06% year-over-year to 0.69; the trailing twelve-month figure through Mar 2026 stood at 0.69 (up 1.06% YoY), and the FY2025 full-year result was 0.71, down 0.98% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.69, up from 0.68 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.93 in Q3 2023, with the low at 0.57 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.68 across 5 years, with a median of 0.68 in 2025.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 42.26% — and 2024, when it slumped 36.52%.
• Journey Medical's Asset Utilization Ratio stood at 0.69 in 2022, then declined by 18.12% to 0.57 in 2023, then jumped by 37.48% to 0.78 in 2024, then decreased by 12.43% to 0.68 in 2025, then gained by 0.98% to 0.69 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.69 (Q1 2026), 0.68 (Q4 2025), and 0.71 (Q3 2025), per Business Quant data.